Please do not use this email for NHS or clinical related matters. Please contact my NHS PA for these enquiries at firstname.lastname@example.org
MD Med MBBS (Hons) BSc (Hons) FRCS (England)
Consultant Oncoplastic Breast Surgeon and Clinical Epidemiologist
Toral Gathani was appointed as a Consultant Oncoplastic Breast Surgeon at the Oxford University Hospitals NHS Trust and Clinical Epidemiologist at the Cancer Epidemiology Unit in 2013. She studied Medicine at the University of St Andrews and Guy’s and St Thomas’ Medical School graduating in 1999 with Honours. She passed the Fellowship of the Royal College of Surgeons in 2010. She subsequently subspecialised in Oncoplastic and Reconstructive Breast Surgery and was awarded a National Oncoplastic Breast Surgery Fellowship at the Nottingham Breast Institute in 2011.
Toral spent time in the Cancer Epidemiology Unit in 2003-2006 when she completed the research for her MD thesis under the supervision of Dame Professor Valerie Beral. She continued to develop her interest in epidemiology during her specialist surgical training and has spent a year working in India establishing multicentre studies related to breast cancer.
Her main research interests are in the epidemiology of breast cancer in South Asians and the South Asian diaspora.
Ethnicity and the tumour characteristics of breast cancer in a large nationally representative sample of women in England
Gathani T. et al, (2016), EUROPEAN JOURNAL OF CANCER, 57, S12 - S12
Surgery and risk of venous thromboembolism in women with cancer
Sweetland S. et al, (2014), THROMBOSIS RESEARCH, 133, S191 - S191
The level of agreement of the reporting of breast cancer pathology in eight different cancer centres across India
Gathani T. and Ananthakrishna R., (2014), EUROPEAN JOURNAL OF CANCER, 50, S190 - S191
Characteristics of women who undergo breast reconstruction following mastectomy for breast cancer in the Million Women Study
Gathani T. et al, (2014), EUROPEAN JOURNAL OF CANCER, 50, S106 - S107
Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study.
Gathani T. et al, (2014), Br J Cancer, 110, 224 - 229